A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 37,698 shares of REGN stock, worth $26.9 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
37,698
Holding current value
$26.9 Million
% of portfolio
0.46%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $38.6 Million - $45.3 Million
37,698 New
37,698 $39.6 Million
Q2 2024

Aug 06, 2024

BUY
$883.2 - $1071.19 $839,040 - $1.02 Million
950 Added 2.34%
41,598 $43.7 Million
Q1 2024

May 13, 2024

BUY
$902.69 - $993.35 $476,620 - $524,488
528 Added 1.32%
40,648 $39.1 Million
Q4 2023

Feb 13, 2024

SELL
$775.18 - $881.7 $433,325 - $492,870
-559 Reduced 1.37%
40,120 $35.2 Million
Q3 2023

Nov 08, 2023

SELL
$692.45 - $844.37 $558,114 - $680,562
-806 Reduced 1.94%
40,679 $33.5 Million
Q2 2023

Aug 04, 2023

BUY
$700.03 - $830.35 $1.03 Million - $1.22 Million
1,472 Added 3.68%
41,485 $29.8 Million
Q1 2023

May 09, 2023

SELL
$680.49 - $826.97 $370,186 - $449,871
-544 Reduced 1.34%
40,013 $32.9 Million
Q4 2022

Feb 13, 2023

BUY
$705.89 - $766.39 $686,830 - $745,697
973 Added 2.46%
40,557 $29.3 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $2.28 Million - $2.87 Million
-3,965 Reduced 9.1%
39,584 $27.2 Million
Q2 2022

Aug 08, 2022

BUY
$548.35 - $738.84 $6.07 Million - $8.18 Million
11,078 Added 34.12%
43,549 $25.7 Million
Q1 2022

May 12, 2022

BUY
$595.12 - $698.43 $1.74 Million - $2.04 Million
2,925 Added 9.9%
32,471 $22.8 Million
Q4 2021

Feb 15, 2022

BUY
$543.48 - $670.97 $10.6 Million - $13.1 Million
19,497 Added 194.02%
29,546 $18.9 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $1.74 Million - $2.06 Million
3,030 Added 43.17%
10,049 $6.1 Million
Q2 2021

Aug 06, 2021

BUY
$472.8 - $558.54 $1.99 Million - $2.35 Million
4,206 Added 149.52%
7,019 $3.75 Million
Q1 2021

May 13, 2021

SELL
$446.73 - $548.2 $876,930 - $1.08 Million
-1,963 Reduced 41.1%
2,813 $1.33 Million
Q4 2020

Feb 12, 2021

BUY
$478.3 - $607.98 $260,195 - $330,741
544 Added 12.85%
4,776 $2.31 Million
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $216,810 - $261,967
398 Added 10.38%
4,232 $2.37 Million
Q2 2020

Aug 12, 2020

BUY
$493.32 - $643.92 $1.42 Million - $1.86 Million
2,881 Added 302.31%
3,834 $2.39 Million
Q1 2020

May 13, 2020

BUY
$336.18 - $494.43 $26,222 - $38,565
78 Added 8.91%
953 $465,000
Q4 2019

Feb 13, 2020

BUY
$274.13 - $376.51 $239,863 - $329,446
875 New
875 $328,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Banco Bilbao Vizcaya Argentaria, S.A. Portfolio

Follow Banco Bilbao Vizcaya Argentaria, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.